| 股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
| BBIO BridgeBio Pharma, Inc. | -1,451,214,508.65 | -1,460,742,518.78 | 28,106,052,837.97 |
| BHC Bausch Health Companies Inc. | 26,744,138,782.9 | 24,575,695,097.8 | 21,355,884,777.5 |
| TSHA Taysha Gene Therapies, Inc. | -1,328,171,757.12 | -1,328,138,901.92 | 5,790,106,046.5 |
| 6472 保瑞 | 688,938,000 | 454,238,000 | 3,696,457,000 |
| SUPN Supernus, Inc. | 3,154,099,905.6 | 2,694,127,002.7 | 2,694,127,002.7 |
| AMPH Amphastar Pharmaceuticals, Inc. | 1,686,260,662.03 | 1,404,001,575.69 | 1,730,648,047.16 |
| RDY Dr. Reddy's Laboratories Limited | 1,808,289,633.28 | 986,962,017.86 | 681,359,700.96 |
| 3705 永信 | 327,770,000 | 208,390,000 | 563,414,000 |
| SLGL SOL-GEL TECHNOLOGIES LTD. | -282,127,665.51 | -281,536,271.78 | 462,272,767.41 |
| 1795 美時 | 701,365,000 | 603,443,000 | 150,870,000 |
| PSNL Personalis, Inc. | -889,456,173.38 | -990,420,225.57 | 141,375,957.23 |
| 6461 益得 | -85,138,000 | -98,472,000 | 44,980,000 |
| ASMB Assembly Biosciences Inc | -508,861,451.44 | -508,861,451.44 | 38,309,171.77 |
| CPHI China Pharma Holdings Inc | -1,078,636.46 | 4,481,450.28 | |
| 6130 上亞科技 | 9,442,000 | 9,042,000 | -3,556,000 |
| 1720 生達 | 607,518,000 | 496,706,000 | -105,170,000 |
| 4120 友華 | -305,129,000 | -376,627,000 | -185,264,000 |
| 4747 強生* | 14,405,000 | 2,196,000 | -765,190,000 |
| TEVA Teva Pharmaceutical Industries Limited | 13,536,345,428.2 | 10,086,548,656.45 | -2,825,547,832.1 |
載入數據中...
最新要聞
和學名藥相關的產業概念股
學名藥概念股相關指標排名
學名藥每月營收
學名藥每股盈餘
學名藥每股淨值
學名藥損益表
學名藥總資產
學名藥負債和股東權益
學名藥現金流量表
學名藥利潤比率
學名藥營業費用率拆解
學名藥杜邦分析
學名藥ROE / ROA
學名藥經營週轉能力
學名藥營運週轉天數
學名藥現金股利發放率
學名藥財務結構比率
學名藥流速動比率
學名藥利息保障倍數
學名藥現金流量分析
學名藥營業現金流對淨利比
學名藥盈餘再投資比率
學名藥月營收成長率
學名藥營收成長率
學名藥毛利成長率
學名藥營業利益成長率
學名藥稅後淨利成長率
學名藥每股盈餘成長率
學名藥本益比評價
學名藥股價淨值比評價
學名藥現金股利殖利率
學名藥平均現金股息殖利率
學名藥董監持股比例
學名藥董監持股質押比例